The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
SP can move up ( and I mean well above 200) with or without news simply with technicals, simple.
Besides, some expected news will come along in the meanwhile to further support the move.
But no-one can say he is sure of what will unfold.
We are gaining strength and seems we are moving north, simple.
Let's be serious
Yes and this is also stated under Section 2 (c) of Biden's Executive order:
Sec. 2. Accelerating the Development of Novel Therapies. To enhance the Nation’s ability to quickly develop the most promising COVID-19 interventions, the Secretary of Health and Human Services (HHS), in consultation with the Director of the National Institutes of Health, shall:
(a) develop a plan for supporting a range of studies, including large-scale randomized trials, for identifying optimal clinical management strategies, and for supporting the most promising treatments for COVID-19 and future high-consequence public health threats, that can be easily manufactured, distributed, and administered, both domestically and internationally;
(b) develop a plan, in consultation with non-governmental partners, as appropriate, to support research:
(i) in rural hospitals and other rural locations; and
(ii) that studies the emerging evidence concerning the long-term impact of COVID-19 on patient health; and
(c) consider steps to ensure that clinical trials include populations that have been historically underrepresented in such trials.
Parexel is teaming up with Signify Health to better understand the diversity of patients in clinical trials and re-model their studies accordingly.
The new partnership will focus on “improving patient access to clinical trials, bringing studies to patients in their own homes, and identifying relevant social determinants of health (SDoH) to facilitate connections among local resources, patients, and caregivers,”
“Alongside this clinical support, we are identifying and addressing the social comorbidities that impact a person’s ability to access the care they need. It is particularly exciting to be working with Parexel on ways to leverage these capabilities to support both patients, and their caregivers, who want to participate in clinical trial programs for potentially life-changing therapies.”
https://www.fiercebiotech.com/cro/parexel-signify-join-forces-to-better-diversity-clinical-trials
Consider that Citadel will be closing their short position presumably today.
IIs and those with dma can potentially influence the price playing with the order books in order to get their orders favourably filled.
This is not rocket science and for who is asking why not the sudden rise i can suggest to gain some knowledge of how the things work.
All very positive in terms of how the company is progressing.
And more importantly.. ignore the idiots.
"We are going to lead with Science and Truth. We believe in both".
Biden’s plan aims to “restore U.S. leadership globally,” including supporting international health and humanitarian efforts, and working with other countries to develop and share treatments.
400 billions out of the total 1.9 trillions aimed at strengthening pandemic preparedness.
https://www.nbcnews.com/politics/politics-news/biden-announces-new-science-team-elevates-office-cabinet-n1254518
Debarra
Lots of effort you put in your 8th post.
What you forgot or ignored is that SNG001 is a broad spectrum antiviral and it will be also used in the future in addition to Covid for any viral pulmonary infections including asthma copd and various Influenza.
So your maths make small or no sense at all.
Synairgen if succesful will never be bought out for less than 5 billions.
Forget these stupid things.
Let the company do their work without interfering and create unnecessary noise.
Done with good intention but not a good idea. Forget about it.
Synairgen is capable enough to do their own things without silly petitions.